SC 13D/A

AMENDMENT NO. 10 TO SCHEDULE 13D

Company: Cartesian Therapeutics, Inc.
Filed: September 25, 2023
Accession Number: 0001213900-23-078889

View Document ↗ View on SEC.gov ↗